|
Volumn 7, Issue 6, 2005, Pages E7-
|
CYP2D6 variants and the prediction of tamoxifen response in randomized patients: author response
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
CYTOCHROME P450 2D6;
TAMOXIFEN;
BREAST NEOPLASMS;
ENZYMOLOGY;
FEMALE;
GENETICS;
HUMAN;
PATIENT SELECTION;
PROGNOSIS;
REPRODUCIBILITY;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CYTOCHROME P-450 CYP2D6;
FEMALE;
HUMANS;
PATIENT SELECTION;
PROGNOSIS;
REPRODUCIBILITY OF RESULTS;
TAMOXIFEN;
|
EID: 34548610234
PISSN: None
EISSN: 1465542X
Source Type: Journal
DOI: 10.1186/bcr1326 Document Type: Letter |
Times cited : (9)
|
References (0)
|